CD40 (monomer)
Use this icon in our BioRender software along with 1000s of others. Create your next scientific figure in minutes!
SIGN UP FREE[{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee9d/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee9d/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee9c/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee9c/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee9b/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee9b/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee9a/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee9a/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee99/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee99/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee98/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee98/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee97/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee97/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee96/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee96/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee95/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee95/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee94/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee94/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee93/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee93/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee92/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee92/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee91/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee91/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee90/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee90/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee8f/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee8f/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee8e/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee8e/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee8d/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee8d/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee8c/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee8c/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee8b/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee8b/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee8a/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee8a/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee89/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee89/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee88/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee88/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee87/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee87/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee86/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee86/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee85/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee85/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee84/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee84/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee83/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee83/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee82/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee82/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee81/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee81/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee80/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee80/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee7f/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee7f/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee7e/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee7e/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee7d/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee7d/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee7c/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee7c/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee7b/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee7b/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee7a/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee7a/cd40-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f6b64b40d0e450028a8ee79/cd40-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f6b64b40d0e450028a8ee79/cd40-monomer.png"}]
Keywords
CD40,Bp50,CDW40,TNFRSF5,p50,cluster of differentation,costimulator,antigen presenting cell,apc,hyper igm syndrome,CD154,T helper,CD40,vp50,CDW40,TNFRS5,p50